ratiotx
Scientist/Sr. Scientist, Radiopharma Development and Tech Transfer (Boston or Salt Lake City)
Boston, Massachusetts · Senior
Sponsorship not specifiedDetected 20 days ago
Project ManagementGMPResearchMicrosoft Office
About the role
- About Ratio Therapeutics Ratio Therapeutics is committed to improving and extending the lives of cancer patients without sacrificing their quality of life.
- Join us in our quest to become the leading innovator in radioligand therapy and improve the lives of cancer patients and their families.
- About the Position Ratio is seeking a Scientist/Senior Scientist to join our growing team of scientists.
Responsibilities
- Independently develop and optimize radiopharmaceutical production processes to support advancement of Ratio's lead compounds.
- Lead the transition of early-phase drug product candidate production methods to processes appropriate for GMP technology transfer.
- Design and execute phase-appropriate process development strategies, including process qualification/verification/validation suitable for tech transfer and regulatory submissions.
- Lead manufacturing process training for manufacturing personnel.
- Support OOS/OOT and deviation investigations, identify root cause(s) and implement corrective and preventive actions related to manufacturing operations.
Requirements
- Prior experience working with radioactive materials is required.
- Experience with project management (experience managing external CROs or CDMOs is an asset).
- Occasional business travel may be required (approximately 10%, Contiguous US) to facilitate technology transfer and troubleshooting activities at CDMO and internal sites.
Compensation
- About Ratio Therapeutics
- Ratio Therapeutics is committed to improving and extending the lives of cancer patients without sacrificing their quality of life.
- We are a team of passionate scientists, engineers, and business professionals dedicated to advancing the field of targeted radioligand therapy.
- To accomplish this, we utilize our proprietary TRILLIUM™ and MACROPA™ platforms: TRILLIUM™ allows fine-tuning of radioligand pharmacokinetics thereby enhancing the therapeutic index, while MACROPA™ simplifies the manufacturing process for the alpha-emitting isotope, actinium-225.
- These enabling platform technologies have resulted in an emergent pipeline of novel therapeutic candidates.
- We are looking for talented, dedicated, and creative individuals eager to help us advance these technologies from discovery research through clinical development.
Apply directly at ratiotx →Create a free account for alerts like thisView ratiotx immigration profile
This listing is sourced directly from ratiotx's careers page and normalized into a canonical job model.